High-Fiber diet may cut Early-Onset bowel cancer risk
NCT ID NCT07279454
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a modified high-fiber version of the UK's EatWell diet can improve health markers linked to early-onset colorectal cancer. Two hundred adults in the UK will follow either the standard EatWell diet (30g fiber/day) or a modified version (40g fiber/day) for 12 weeks. Researchers will measure changes in stool, blood, urine, and saliva to see if extra fiber makes a difference.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Modified EatWell diet (high-fiber, 40g/day)
What this could lead to
If it works, this could point toward a dietary approach to lower the risk of early-onset bowel cancer.
What could go wrong
This is a small, early-stage trial looking at biological markers, not cancer itself. The diet may be hard to follow long-term, and results may not translate to actual cancer prevention.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MICROBIOME RELATED MECHANISMS LINKED TO EARLY ONSET COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Twin Research and Genetics
London, SE1 7EH, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••